Clinical Trials Browser

Breast Neoplasms

NCT00066690 2026-02-06

SOFT

Phase 3 Completed

3,066 enrolled 15 charts

Breast

Breast Neoplasms

NCT00066703 2026-02-06

TEXT

Phase 3 Completed

2,672 enrolled 14 charts

Breast

Breast Neoplasms

NCT00601900 2025-05-23

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

Phase 3 Completed

394 enrolled 11 charts

Breast

Breast Neoplasms

NCT00949598 2025-02-13

Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer

Phase 3 Completed

177 enrolled

Breast

Breast Neoplasms

NCT00002644 2024-12-11

IBIS-1

Phase 3 Completed

7,154 enrolled

Breast

Breast Neoplasms

NCT00072462 2024-09-19

IBIS-II DCIS

Phase 3 Completed

2,980 enrolled 14 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00295646 2024-03-15

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Phase 3 Completed

1,803 enrolled 20 charts

Breast

Breast Neoplasms

NCT02278120 2024-03-12

MONALEESA-7

Phase 3 Completed

672 enrolled 16 charts 1 FDA

Breast

Advanced Metastatic Breast Cancer

NCT00309478 2023-06-29

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

Phase 3 Completed

1,099 enrolled

Breast

Breast Neoplasms

NCT00004125 2023-06-15

Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

Phase 3 Completed

Breast

Breast Neoplasms

NCT00433589 2022-11-17

MINDACT

Phase 3 Completed

6,600 enrolled

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT00003857 2022-05-25

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Phase 3 Completed

636 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00309491 2020-10-19

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

Phase 3 Completed

2,021 enrolled

Breast

Breast Neoplasms

NCT00005970 2020-08-14

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Phase 3 Completed

3,436 enrolled

Breast

Breast Neoplasms

NCT01950182 2020-07-15

SYSUCC-002

Phase 3 Completed

392 enrolled

Breast

Breast Neoplasms

NCT00002542 2020-04-01

Tamoxifen in Treating Women With High-Risk Breast Cancer

Phase 3 Completed

672 enrolled

Breast

Breast Neoplasms

NCT00002864 2020-04-01

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Phase 3 Completed

667 enrolled

Breast

Breast Neoplasms

NCT00003032 2020-04-01

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

Phase 3 Completed

224 enrolled

Breast

Breast Neoplasms

NCT00041080 2019-07-30

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Phase 3 Completed

139 enrolled 10 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT02995772 2019-06-19

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

Phase 3 Completed

122 enrolled

Breast

Breast Neoplasms

NCT00053898 2018-09-20

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Phase 3 Completed

3,104 enrolled 16 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01638247 2018-09-19

MALE

Phase 3 Completed

56 enrolled

Breast

Breast Neoplasms, Male

NCT00687102 2018-09-12

Co-STAR

Phase 3 Completed

1,498 enrolled 13 charts

Breast

Breast Neoplasms

NCT00004205 2017-12-12

BIG 1-98

Phase 3 Completed

8,028 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Ductal, Breast

NCT00590785 2017-08-25

Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

Phase 3 Completed

60 enrolled

Breast

Breast Neoplasms

NCT00171704 2017-03-03

A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

Phase 3 Completed

263 enrolled 12 charts

Breast

Breast Neoplasms

NCT00293540 2016-07-27

Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

Phase 3 Completed

249 enrolled 9 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00659373 2016-07-25

Co-SOFT

Phase 3 Completed

86 enrolled 4 charts

Breast

Breast Neoplasms, Fatigue, Sleep Wake Disorders

NCT02728622 2016-04-05

Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane

Phase 3 Completed

241 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00036270 2015-10-28

TEAM

Phase 3 Completed

9,779 enrolled 13 charts

Breast

Breast Neoplasms

NCT00003906 2015-10-06

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Phase 3 Completed

19,747 enrolled

Breast

Breast Neoplasms

NCT00201851 2015-04-29

Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

Phase 3 Completed

740 enrolled 14 charts

Breast

Breast Neoplasms

NCT00038467 2014-05-07

IES

Phase 3 Completed

4,740 enrolled 31 charts

Breast

Breast Neoplasms

NCT00002579 2013-11-06

Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer

Phase 3 Completed

2,000 enrolled

Breast

Breast Neoplasms

NCT00002580 2013-11-06

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

Phase 3 Completed

1,000 enrolled

Breast

Breast Neoplasms

NCT00002581 2013-11-06

Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer

Phase 3 Completed

1,000 enrolled

Breast

Breast Neoplasms

NCT00002755 2013-11-06

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Phase 3 Completed

600 enrolled

Breast

Breast Neoplasms

NCT00002720 2013-09-20

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer

Phase 3 Completed

642 enrolled

Breast

Breast Neoplasms

NCT00003013 2013-09-17

Chemotherapy Plus Surgery in Treating Women With Breast Cancer

Phase 3 Completed

450 enrolled

Breast

Breast Neoplasms

NCT00002582 2013-08-02

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Phase 3 Completed

6,000 enrolled

Breast

Breast Neoplasms

NCT00032136 2013-08-02

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Phase 3 Completed

4,400 enrolled

Breast

Breast Neoplasms

NCT00003424 2013-06-26

Tamoxifen in Treating Patients With Primary Liver Cancer

Phase 3 Completed

300 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00002967 2013-06-21

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Phase 3 Completed

Breast

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT00047099 2013-05-30

Combination Chemotherapy in Treating Women With Breast Cancer

Phase 3 Completed

446 enrolled

Breast

Breast Neoplasms

NCT00002528 2013-04-04

10-93

Phase 3 Completed

473 enrolled

Breast

Breast Neoplasms

NCT00002529 2013-04-04

12-93

Phase 3 Completed

452 enrolled

Breast

Breast Neoplasms

NCT00002784 2013-04-04

15-95

Phase 3 Completed

344 enrolled

Breast

Breast Neoplasms

NCT00291759 2013-01-30

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

Phase 3 Completed

3,858 enrolled

Breast

Breast Neoplasms

NCT00929591 2013-01-24

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

Phase 3 Completed

1,558 enrolled

Breast

Breast Neoplasms

Clinical Trials

MNEMOSYNE

SOFT

TEXT

Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer

Letrozole or Tamoxifen Citrate in Treating Older Postmenopausal Women Undergoing Surgery for Breast Cancer

IBIS-1

IBIS-II DCIS

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

MONALEESA-7

Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients

Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes

MINDACT

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

SYSUCC-002

Tamoxifen in Treating Women With High-Risk Breast Cancer

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

MALE

Co-STAR

BIG 1-98

Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

Co-SOFT

Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane

TEAM

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

IES

Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast Cancer

Chemotherapy Plus Surgery in Treating Women With Breast Cancer

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer

Tamoxifen in Treating Patients With Primary Liver Cancer

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Combination Chemotherapy in Treating Women With Breast Cancer

10-93

12-93

15-95

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer